MRNA 8-K 2026-09-01

Moderna, Inc. (MRNA) 8-K dated 2026-09-01 — accession 0001193125-26-378505. This URL is the filing, not the MRNA hub.

Moderna, Inc. (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..

Moderna, Inc. filed a 8-K on 2026-09-01. Accession 0001193125-26-378505.

Cached items: 1.01, 2.03, 3.02, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.

Not investment advice. The MRNA SEC hub lists recent forms. The stock page is the research view.